Improving patient expectations before heart rhythm catheter ablation for atrial fibrillation
Tests whether improving expectations before catheter ablation affects adults with atrial fibrillation.
Plain-language title generated from the registry record
Registry title: Optimizing Quality of Life by Improved Patient Expectation Following Atrial Fibrillation Catheter Ablation
Key facts
- Where
- Düsseldorf and Essen, GermanySee the 2 sites
Where in Germany
- Evangelic Hospital DüsseldorfDüsseldorf, GermanyTaking people
- Westdeutsches Herz- und GefäßzentrumEssen, GermanyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Evangelical Hospital Düsseldorf
- Trial code
- NCT05557526
- Record updated
- 28 April 2026
- Original description
The aim is to investigate whether optimizing patients' expectations towards the interventional treatment of atrial fibrillation (catheter ablation) leads to a lower disease-related impairment of the patients compared to the control group in the first three months after ablation (the so-called blanking period).Read full original descriptionShow less
Optimizing Quality of Life by Improved Patient Expectation Following Atrial Fibrillation Catheter Ablation
The aim is to investigate whether optimizing patients' expectations towards the interventional treatment of atrial fibrillation (catheter ablation) leads to a lower disease-related impairment of the patients compared to the control group in the first three months after ablation (the so-called blanking period).
Inclusion: symptomatic atrial fibrillation; indication for pulmonary vein isolation; sufficient command of the German language.
Exclusion: presence of psychiatric disorders which impair the study participitatin; presence of another medical condiction which influences quality of life stronger than the cardiac condition; atrial fibrillation induced by intoxication, medicamentation or infection; age <18 years; permanent atrial fibrillation; inability to grap the course of the study.